Complex Innovative Design
Decentralized Clinical Trials
European Medicines Agency
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Outsourcing Clinical Trials
Real-World Evidence (RWE)
Research & Development
Research and Development
Robotic-Assisted Surgery (RAS)
RWE Decision Alert
Medtech CDMO: Market and M&A Global Trends in 2024
This webinar replay investigates the current state of the global medtech CDMO industry and highlight Europe as a promising frontier for consolidation.
Clinical Trials & Hospital Pilots
Kenny Carberry, VP, Business Development, Research & Clinical Development, joins the “Clinical Trials & Hospital Pilots” webinar as speaker.
MedTech World: Interview with Gabriele Brambilla, Season 2
Gabriele Brambilla returned to the MedTech World Podcast to discuss the power the CARES Act gives patients over their digital health data.
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Review current trends shaping the US medical device outsourcing landscape, its performance and business outlook, and sustained M&A activity.
MedTech World: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the MedTech World Podcast to discuss his experiences and journey in the Healthcare industry.
Introduction to Patient Engagement in MedTech in the U.S.
Watch this webinar to discover how the MedTech industry can successfully incorporate patient engagement activities at each stage of the medical device and diagnostic development product lifecycle.
RARECast: Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Technology plays a central role in the future of patient empowerment and decentralized clinical trials. Listen to the podcast to learn more.
Expanding Beyond APAC – MedTech Webinars
Watch these webinars to learn about the strategies, challenges, and best practices of scaling beyond the Asia Pacific MedTech market.
Clinical Trial Management in MedTech & Working with CROs
As a MedTech company, understanding clinical trial management is critical, and working with CROs is part of the journey. Join the webinar to learn about this crucial topic.
What You Should Know About MDR Best Practices, Including PMCF
Discover the major changes introduced by the MDR, including the post-market requirements, and especially the Post-Market Clinical Follow-up (PMCF).
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
U.S. and European Clinical Development for Asian MedTech Startups
Watch this webinar for key considerations for Asian MedTech companies interested in engaging in clinical trials in U.S. and Europe.
U.S. and European Regulatory Strategies for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Capital Raising from U.S. and Europe for Asian MedTech Startups
Replay by APACMed and Alira Health focused on helping Asia Pacific-based MedTech start-ups scale their businesses beyond APAC to the U.S. and Europe.
Alira Health’s Transformation Talks: An Advanced Perspective on Advanced Diagnostics
This month we sat down with members from the Illumina Team to discuss the advanced diagnostic ecosystem and genetic data. Topics include how they have the power to transform healthcare(...)
Alira Health’s Transformation Talks: Overcoming Challenges to Reimbursement in Robotic Surgery for the French Market
Our latest Alira Health Transformation Talks is all about Robotic Surgery.
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
Latest from Alira Health
The 2024 Global Medtech Contract Manufacturing Report: Executive Summary
The Importance of Involving Patients in the Health Technology Assessment Process for Rare Diseases
Experts Annabel de Maria and Ahmad Bechara share how engaging rare disease patients in the HTA process gives them the opportunity to have a meaningful impact.
Biopharma in 2024: The Industry Outlook
Insights from recent J.P. Morgan Healthcare Conference including what's changed in biopharma since last year and what to expect this year.
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Pharma Company Extends to New Markets through Strategic Licensing Agreements
A Swedish pharma company saw a market opportunity to expand access to its proprietary product outside of the Nordics and sought support developing strategic licensing deals.
Pharma Develops e-Health Solution That Prioritizes Patients’ True Unmet Needs
A leading pharma company in the respiratory market sought support developing the right digital platform to expand their patient base and increase retention.
Connect with our biotech experts onsite in Barcelona at Bio-Europe Spring. How can we support your development plan and funding path?
XXII Conferenza Nazionale Sulla Farmaceutica
Meet Giovanni Firenze, Partner Consulting Italy, onsite in Catania and learn more about the impact of the new AIFA reform.
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
Alira Health announced the release of the 2024 Global Medtech Contract Manufacturing Report. This report offers a comprehensive analysis of trends in the global medtech contract manufacturing(...)
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Alira Health Releases Global Report on Robotic-Assisted Surgery (RAS) in Orthopedic Procedures
New analysis reveals the RAS in Orthopedics market is anticipated to grow 10% annually over the next five years, reaching more than 2.5 million procedures in the EU, UK and US.
The 2024 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2024 and beyond.
FDA Approves GAMMAGARD LIQUID Based on Safety Data From an RWE Study
Food and Drug Administration (FDA) approves GAMMAGARD LIQUID based on safety data from a real-world evidence study.
UK HTA Recommends KANUMA in Pediatric Patients Based Partly on Comparative RWD
KANUMA underwent a recent appraisal by the UK's NICE for the treatment of Wolman disease in children aged two years and under.
Best Practices for Health Technology Assessment of Robotic Assisted Surgery
An expert panel developed seven best-practice recommendations for evaluating Robotics Assisted Surgical systems and here are the results.
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Immunoglobulin Fc-Fusion Proteins
Our experts published a series of articles in BioProcess International reviewing the state of the art of Fc – fusion proteins, including their structure and molecular design, manufacturing(...)